The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Proteinuria

Loss of protein in urine above normal; an early warning of kidney disease.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dahiliye (İç Hastalıkları) department. Book Appointment →

What is Proteinuria?

Proteinuria is the excretion of more than 150 mg of protein per day. It can result from damage to the filtration barrier in the renal glomeruli, impaired tubular reabsorption, or excessive elevation of plasma protein concentration. The spot urine albumin/creatinine ratio (30-300 mg/g: microalbuminuria; >300 mg/g: macroalbuminuria) is a practical screening method.

Diabetic nephropathy, hypertensive nephropathy, and glomerulonephritides are the main causes. Proteinuria is not only a finding; it also independently predicts cardiovascular disease risk and the rate of progression of chronic kidney disease.

Protein loss exceeding 3.5 g/day is defined as 'nephrotic-range proteinuria' and is a marker of nephrotic syndrome.

Symptoms

Foamy urine (indicates albumin loss)
Leg, ankle, and facial edema (in severe albumin loss)
Fatigue and general weakness
Mild proteinuria usually has no symptoms (detected incidentally)
Symptoms of underlying disease (diabetes, hypertension)

Risk Factors

Diabetes mellitus (most common cause)
Hypertension
Obesity
Family history of chronic kidney disease
NSAID and nephrotoxic drug use
Autoimmune diseases (lupus, IgA nephropathy)

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • When protein is detected on routine urinalysis, especially with diabetes or hypertension
  • If foamy urine becomes persistent
  • If swelling begins in the legs or face
  • If there is worsening of kidney function tests

Treatment Methods

01
RAAS blockade: ACE inhibitor or ARB — reduces proteinuria and is kidney-protective
02
SGLT2 inhibitors (empagliflozin, dapagliflozin): organ-protective in diabetic and non-diabetic proteinuria
03
Blood pressure target: <130/80 mmHg in the presence of proteinuria
04
Strict glycemic control in diabetic patients
05
Salt restriction and adequate (not excessive) protein intake
06
Immunosuppressive therapy (with nephrology follow-up) for underlying glomerular disease

Which Department to Visit?

You can visit our Dahiliye (İç Hastalıkları) department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Dahiliye (İç Hastalıkları) Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.